Graves' disease
RecruitingStudy of IMVT-1402 Treatment for Adults with Graves' Disease
- Disease:Graves' disease
- Substances:IMEROPRUBART
Poland- Participants:18–64 years · 65+ years
- Substances:IMEROPRUBART
- Sponsor:Immunovant Sciences GmbH
Rare diseases
Investigational molecules
Locations
Back to Poland142 clinical trials in Opole, Poland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on heart failure treatments, including investigations of medications like sacubitril/valsartan for various cardiac conditions. Research encompasses both acute and chronic heart conditions.
Multiple trials exploring treatments for patients with reduced ejection fraction and acute cardiac conditions.
Comprehensive research into various cancer types, with particular focus on breast cancer and prostate cancer treatments. Studies evaluate novel therapeutic approaches and drug combinations.
Investigations include both early-stage and advanced cancer treatments using innovative therapeutic agents.
Studies examining treatments for autoimmune conditions and inflammatory disorders, including research on novel therapies for psoriatic arthritis and urticaria.
Clinical investigations focus on improving patient outcomes through targeted immunological interventions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.